Patterns and predictors of transition between multiple sclerosis phenotypes: A longitudinal analysis
Multiple Sclerosis Journal – Experimental, Translational and Clinical · 2026-07 · 12 (3)
DOI: 10.1177/20552173261473717 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multiple Sclerosis Journal – Experimental, Translational and Clinical, online erschienen am 13.08.2026. Verfasst von Gauruv Bose und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sanofi.
Abstract (Originalsprache)
Background
Multiple sclerosis (MS) phenotype transitions are challenging to characterize. Our understanding of their predictors is also limited.
Objective
To investigate the transition between relapsing-remitting MS (RRMS) and secondary progressive MS (SPMS) within the Comprehensive Longitudinal Investigation of MS at the Brigham and Women's Hospital (CLIMB) study.
Methods
This retrospective study included adult people with MS having ≥10-year follow-up data who were classified as RRMS, primary progressive MS, and SPMS (active SPMS [aSPMS]: with relapse; nonrelapsing SPMS [nrSPMS]: no relapses within 2-year pre-index). Demographics, disability scores, and transition predictors were assessed.
Results
Ninety-seven of 565 people with RRMS (17.2%) transitioned to SPMS, of whom 92.8% ( n = 90/97) were classified as nrSPMS by the final visit. People with RRMS who transitioned to nrSPMS were older (mean age, 53.1 vs. 45.4 years; P < 0.001) and took longer time to transition (mean, 13.0 vs. 7.8 years; P < 0.001) than those who transitioned to aSPMS. Older age at MS onset and a high number of disease-modifying therapy switches were significantly associated with a shorter time-to-nrSPMS transition ( P ≤ 0.001).
Conclusion
This study provides a comprehensive characterization of MS phenotype transitions, that may enhance clinical decision-making and therapeutic targeting of underlying pathophysiology driving disability in progressive MS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
- Department of Medicine (Neurology), University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada.
- Health Economics and Value Assessment (HEVA), Neurology and Immunology, Sanofi, Cambridge, MA, USA.
- Department of Neurology, Harvard Medical School, Harvard University, Boston, MA, USA.
ORCID-Profile: Gauruv Bose, Brian C Healy, Tanuja Chitnis
Förderung
- Sanofi
Zitieren
APA
Bose, G., Greene, N., Healy, B. C., Weiner, H. L., Farnett, L., Higuchi, K., & Chitnis, T. (2026). Patterns and predictors of transition between multiple sclerosis phenotypes: A longitudinal analysis. Multiple Sclerosis Journal – Experimental, Translational and Clinical, 12(3). https://doi.org/10.1177/20552173261473717
Vancouver
Bose G, Greene N, Healy BC, Weiner HL, Farnett L, Higuchi K, et al. Patterns and predictors of transition between multiple sclerosis phenotypes: A longitudinal analysis. Multiple Sclerosis Journal – Experimental, Translational and Clinical. 2026;12(3). doi:10.1177/20552173261473717
BibTeX
@article{Bose2026,
author = {Bose, Gauruv and Greene, Nupur and Healy, Brian C and Weiner, Howard L and Farnett, Lisa and Higuchi, Keiko and Chitnis, Tanuja},
title = {Patterns and predictors of transition between multiple sclerosis phenotypes: A longitudinal analysis},
journal = {Multiple Sclerosis Journal – Experimental, Translational and Clinical},
year = {2026},
volume = {12},
number = {3},
doi = {10.1177/20552173261473717}
}
EUVIMED